Edward G. Stopa

Multiplicity of cerebrospinal fluid functions: New challenges in health and disease

Conrad E. Johanson, John A. Duncan, Petra M. Klinge et al. · Cerebrospinal Fluid Research · 2008 · 841 citations · Full text

Advanced glycation end products contribute to amyloidosis in Alzheimer disease.

Michael P. Vitek, Koushik Bhattacharya, J M Glendening et al. · Proceedings of the National Academy of Sciences · 1994 · 795 citations · Full text

Glycobiology, Alzheimer's Disease, Bioanalysis +17

Putative Melatonin Receptors in a Human Biological Clock

Steven M. Reppert, David R. Weaver, Scott A. Rivkees et al. · Science · 1988 · 503 citations

Social Sciences, Neuroendocrine Mechanism, Hypothalamic Peptide +17

RAGE, LRP-1, and amyloid-beta protein in Alzheimer’s disease

John E. Donahue, Stephanie Flaherty, Conrad E. Johanson et al. · Acta Neuropathologica · 2006 · 494 citations

Neurodegenerative Diseases, Alzheimer's Disease, Neurochemical Biomarkers +5

Microvascular injury and blood–brain barrier leakage in Alzheimer's disease

Brian D. Zipser, Conrad E. Johanson, L. González et al. · Neurobiology of Aging · 2006 · 471 citations

Neurodegenerative Diseases, Alzheimer's Disease, Blood–brain Barrier +9